Beruflich Dokumente
Kultur Dokumente
a r t i c l e
i n f o
Article history:
Received 21 June 2013
Received in revised form 4 September 2013
Accepted 10 September 2013
Available online 17 September 2013
Keywords:
Halloysite
Alkali activation
Adsorption
Controlled release
Ooxacin
a b s t r a c t
Halloysite nanotubes are promising vehicles for the controlled release of drug molecules. Here, we systematically investigated the effects of alkali activation on the physicochemical properties, structure and
morphology of halloysite nanotubes by XRD, FTIR, SEM and TEM, etc. Afterwards, the adsorption and
in vitro release properties of halloysite for cationic ooxacin (OFL) were evaluated. The results indicate
that alkali activation dissolves amorphous aluminosilicate, free silica and alumina, which results in the
increase in pore volume and pore size. OFL is adsorbed onto halloysite via electrostatic interaction and
complexation. Alkali activation could increase the adsorption capacity of halloysite for OFL and prolong
release of the adsorbed OFL compared with the natural halloysite. Thus, alkali activation of halloysite is
an effective protocol to improve the adsorption and prolong release for cationic drug molecules.
2013 Elsevier B.V. All rights reserved.
1. Introduction
Recently, some clay minerals, e.g., montmorillonite, hydrotalcite and laponite, are used in pharmaceutical technology as ideal
excipients and substances with suitable biological activity due to
their excellent properties including chemical inertness, good biocompatibility, high specic surfaces areas, large pore volumes, and
mechanical stability [1,2]. Halloysite (Al2 (OH)4 Si2 O5 2H2 O) is a
tubular clay mineral. The external surface of halloysite is composed
of siloxane (SiOSi) groups and the internal surface consists of
a gibbsite-like array of aluminol (AlOH) groups. The difference
in composition of external and internal surfaces results in a negatively charged external surface and a positively charged inner
lumen in pH 28 aqueous solutions [35]. Halloysite nanotubes
are important nano-vehicles for encapsulation of many biologically
and chemically active substances due to the nano-tubular structure and good biocompatibility [68]. Many drug molecules such
as proteins, resveratrol [9], tetracycline hydrochloride [10] and
doxorubicin [11] have been loaded onto halloysite. However, the
adsorption capacity of natural halloysite for drug is often low. For
example, the adsorption capacity of halloysite for 5-aminosalicylic
acid is only about 4.00 mg/g [12].
Many literatures have reported that an increase in the lumen
diameter of halloysite or modication of halloysite with polymers
can improve adsorption capacity of halloysite for drug molecules
[13,14]. For instance, H2 SO4 activation at certain temperature can
(1)
where w is the mass of OFL used for drug loading, mg; c is the
concentration of OFL in the ltrate, mg/mL; v is the volume of the
ltrate, mL; m is the mass of halloysite used for drug loading, g.
2.4. Determination of Al(III)
The concentrations of Al(III) in the supernatant as mentioned
in the above section were determined using Duo View ICP-OES
spectrometer (iCAP 6300MFC, Thermo Fisher Scientic, UK). For
comparison, the leaching of Al(III) from halloysite samples in pH
3.0 acetic acid solution was also studied. The only difference is no
OFL was added.
2.5. In vitro release studies
In vitro release experiments were carried out using an intelligent
dissolution apparatus by immersing 0.25 g of the OFL-loaded halloysite samples in 500 mL of pH 1.20 solution (simulated gastric
uid). The mixture was stirred at 50 rpm and 37 1 C. At predetermined time intervals, 5 mL of the solution was taken and the
same amount of the fresh dissolution media was added back to
maintain a constant volume. The collected 5 mL of the solution was
ltrated through a membrane with a pore diameter of 0.45 m.
The ltrate (3 mL) was diluted to 10 mL with the fresh dissolution media. The concentration of OFL was determined by a UVvis
spectrophotometer at 293 nm, and then the cumulative release percentage of OFL was obtained. The cumulative release results are the
average of three measurements.
2.6. Characterization
FTIR spectra of samples were recorded on a Thermo Nicolet NEXUS TM spectrophotometer using a KBr pellet. The
morphology and microscopic structures of the samples were
observed using FE-SEM (JSM-6701F, JEOL, Ltd.) and TEM (TECNAIG2-F30, FEI). The specic surface area of the samples was
determined by the BrunauerEmmettTeller (BET) method. The
pore volume and pore-size distribution were estimated by the
55
56
Fig. 1. FE-SEM images of (a) 0 (natural halloysite), (b) 0.5, (c) 4.0 and (d) 6.0 mol/L NaOH solution treated halloysite.
ascribed to another characteristic peak of tubular halloysite disappears, indicating etching of alumina [15]. Moreover, the intensity of
the characteristic peak of alumite (KAl3 (SO4 )2 (OH)6 ) at 29.9 gradually decreases with increasing NaOH concentration. The results
suggest that the crystal structure of halloysite has been partly
changes after treated with 6.0 mol/L NaOH solution.
Fig. 2. TEM images of (a) natural halloysite (5000), (b) natural halloysite (29,500), (c) natural halloysite (75,000), (d) 0.5 mol/L NaOH solution treated halloysite (12,000).
(For interpretation of the references to color in this gure legend, the reader is referred to the web version of this article.)
57
911 cm1 is ascribed to the bending vibration of the inner OH. The
broad band at 1638 cm1 in Fig. 4a is owing to bending vibration
of adsorbed water. The band at 1114 cm1 is assigned to the apical SiO and that at 1030 cm1 to perpendicular SiO stretching
vibration. The band at 536 cm1 is due to SiO bending mode and
that at 469 cm1 to AlO stretching mode [25]. After treated with
NaOH solution, these intensities of the absorption bands at 3693,
3621 and 911 cm1 decrease with increasing NaOH concentration
(Fig. 4bd), indicating the gradual removal of alumina layers [15],
which is consistent with the XRD results. The peaks of SiOH vibrations at 3525 and 3450 cm1 also gradually disappear. In addition,
decreases in intensities of the peaks at 1030, 536 and 469 cm1
was observed. The FTIR results indicate that alkali-activation could
remove some SiOH and AlOH groups from halloysite.
3.4. Thermal analysis
The decomposition process of the halloysite samples is composed of three main steps according to the TGA and DSC curves
(Figs. 5 and 6) [26]. (i) The rst evident weight loss in TGA curves at
around 91 C is attributed to the dehydration of physisorbed water
and interlayer water. (ii) The second evident weight loss at about
297 C is attributed to the structural decomposition of alunite.
However, this endothermic peak disappears for halloysite treated
by 6 mol/L NaOH solution. This result further proves that alunite
is removed during alkali activation. (iii) The third evident weight
loss appears at 542 C owing to the dehydroxylation of structural
water. The weight loss of halloysite decreases with increasing NaOH
Fig. 4. FTIR spectra of (a) 0 (natural halloysite), (b) 0.5, (c) 4.0 and (d) 6.0 mol/L NaOH solution treated halloysite.
58
0.5
4.0
6.0
32.76
0.088
10.71
33.82
0.096
11.32
34.77
0.101
11.60
39.21
0.120
12.24
Table 2
Adsorption capacities for OFL in pH 3.0 solution, zeta potential, and pH of original and nal solutions of natural and alkali-activated halloysite samples.
NaOH concentration (mol/L)
0
0.5
4.0
6.0
OFL
OFL-loaded activated halloysite (4 mol/L NaOH)
44.70 0.57
55.26 0.44
59.17 0.65
62.77 0.49
a
b
Initial pHa
Final pHb
4.56
4.57
4.56
4.57
5.43
6.29
6.57
6.63
0.1 g OFL was dissolved in 50 mL of pH 3.0 dilute acetic acid solution and no halloysite was added.
0.1 g OFL was dissolved in 50 mL of pH 3.0 dilute acetic acid solution, and 1.0 g of halloysite was added, and then the OFL-loaded halloysite was removed from the solution.
59
Fig. 10. Pore size distribution of halloysite sample treated with 0.5 mol/L NaOH
solution before and after OFL adsorption.
60
activation at room temperature has no obvious effect on the crystal structure of halloysite when the NaOH concentration is less
than 4.0 mol/L. Both BET and pore volume of halloysite increase
with increasing NaOH concentration. OFL is adsorbed onto halloysite via electrostatic interaction between protonated OFL and
negative halloysite surface, and the complexation between OFL and
amorphous Al(III) in the lumen of halloysite nanotube. Increases in
both BET and pore volume of halloysite improve the OFL adsorption
capacity though the ligand-promoted dissolution could result in the
decrease of adsorption capacity of halloysite for OFL. OFL also enters
into the lumen of halloysite besides the external surface adsorption.
Alkali activation can prolong the release of the adsorbed OFL and
is proved to be an effective approach to improve adsorption and
release for cationic drugs.
Acknowledgments
The authors are thankful for the joint supports of the National
Youth Natural Science Foundation of China (No. 51003112) and
the Special Research Fund of Scholarship of Dean of CAS.
References
Fig. 11. In vitro release of OFL from natural and alkali-activated halloysite samples
(a) pH 1.2 and (b) pH 7.4.
Table 3
The kinetic constants (k), diffusional exponents (n), and correlative coefcients (r2 )
following linear regression of release data of natural and alkali-treated halloysite at
pH 1.2 and 7.4 media.
NaOH concentration
(mol/L)
0
0.5
4.0
6.0
pH 1.2
pH 7.4
n1
k1
r1 2
n2
k2
r2 2
0.235
0.240
0.251
0.194
34.43
28.12
17.86
22.91
0.977
0.947
0.969
0.960
0.306
0.337
0.341
0.297
24.27
19.05
15.28
18.32
0.975
0.972
0.957
0.974
[1] G.V. Joshi, B.D. Kevadiya, H.C. Bajaj, Design and evaluation of controlled drug
delivery system of buspirone using inorganic layered clay mineral, Microporous
Mesoporous Mater. 132 (2010) 526530.
[2] A. Lpez-Galindo, C. Viseras, P. Cerezo, Compositional, technical and safety
specications of clays to be used as pharmaceutical and cosmetic products,
Appl. Clay Sci. 36 (2007) 5163.
[3] V. Vergaro, E. Abdullayev, R. Cingolani, Y. Lvov, S. Leporatti, Halloysite clay
nanotubes: characterization and biocompatibility study, Biomacromolecules
11 (2010) 820828.
[4] W.N. Xing, L. Ni, P.W. Huo, Z.Y. Lu, X.L. Liu, Y.Y. Luo, Y.S. Yan, Preparation high
photocatalytic activity of CdS/halloysite nanotubes (HNTs) nanocomposites
with hydrothermal method, Appl. Surf. Sci. 259 (2012) 698704.
[5] L. Guimares, A.N. Enyashin, G. Seifert, H.A. Duarte, Structural, electronic, and
mechanical properties of single-walled halloysite nanotube models, J. Phys.
Chem. C 114 (2010) 1135811363.
[6] S.R. Levis, P.B. Deasy, Characterisation of halloysite for use as a microtubular
drug delivery system, Int. J. Pharm. 243 (2002) 125134.
[7] R.R. Price, B.P. Gaber, Y. Lvov, In vitro release characteristics of tetracycline HCl,
khellin and nicotinamide adenine dinucleotide from halloysite a cylindrical
material, J. Microencapsulation 18 (2001) 713722.
[8] N. Veerabadran, R. Price, Y. Lvov, Clay nanotubules for drug encapsulation and
sustained release, Nano 2 (2007) 215222.
[9] V. Vergaro, Y.M. Lvov, S. Leporatti, Halloysite clay nanotubes for resveratrol
delivery to cancer cells, Macromol. Biosci. 12 (2012) 12651271.
[10] R.L. Qi, R. Guo, M.W. Shen, X.Y. Cao, L.Q. Zhang, J.J. Xu, J.Y. Yu, X.Y. Shi, Electrospun poly(lactic-co-glycolic acid)/halloysite nanotube composite nanobers
for drug encapsulation and sustained release, J. Mater. Chem. 20 (2010)
1062210629.
[11] S.G. Wang, Y.L. Wu, R. Guo, Y.P. Huang, S.H. Wen, M.W. Shen, J.H. Wang, X.Y. Shi,
Laponite nanodisks as an efcient platform for doxorubicin delivery to cancer
cells, Langmuir 29 (2013) 50305036.
[12] C. Aguzzi, C. Viseras, P. Cerezo, I. Salcedo, R. Snchez-Espejo, C. Valenzuela,
Release kinetics of 5-aminosalicylic acid from halloysite, Colloids Surf., B 105
(2013) 7580.
[13] A.B. Zhang, L. Pan, H.Y. Zhang, S.T. Liu, Y. Ye, M.S. Xia, X.G. Chen, Effects of
acid treatment on the physico-chemical and pore characteristics of halloysite,
Colloids Surf., A 396 (2012) 182188.
[14] P. Yuan, P.D. Southon, Z.W. Liu, M.E.R. Green, J.M. Hook, S.J. Antill, C.J.
Kepert, Functionalization of halloysite clay nanotubes by grafting with aminopropyltriethoxysilane, J. Phys. Chem. C 112 (2008) 1574215751.
[15] E. Abdullayev, A. Joshi, W.B. Wei, Y.F. Zhao, Y. Lvov, Enlargement of halloysite
clay nanotube lumen by selective etching of aluminum oxide, ACS Nano 6
(2012) 72167226.
[16] I. Hashimoto, M.L. Jackson, Rapid dissolution of allophone and
kaolinitehalloysite after dehydration, in: Seventh National Conference
on Clay and Clay Minerals, 1960, pp. 102113.
[17] R.D. White, D.V. Bavykin, F.C. Walsh, The stability of halloysite nanotubes in
acidic and alkaline aqueous suspensions, Nanotechnology 23 (2012) 065705
(10pp).
[18] J.X. Xu, J.P. Zhang, Q. Wang, A.Q. Wang, Disaggregation of palygorskite crystal bundles via high-pressure homogenization, Appl. Clay Sci. 54 (2011)
118123.
[19] J.P. Zhang, Q. Wang, H. Chen, A.Q. Wang, XRF and nitrogen adsorption of acid
activated palygorskite, Clay Miner. 45 (2010) 145156.
[20] Q. Wang, X.L. Xie, X.W. Zhang, J.P. Zhang, A.Q. Wang, Preparation and swelling
properties of pH sensitive composite hydrogel beads based on chitosan-g-poly
[21]
[22]
[23]
[24]
[25]
[26]
[27]
61
[28] D.V. Bavykin, V.N. Parmon, A.A. Lapkin, F.C. Walsh, The effect of hydrothermal
conditions on the mesoporous structure of TiO2 nanotubes, J. Mater. Chem. 14
(2004) 33703377.
[29] B. Mu, P. Liu, X.R. Li, P.C. Du, Y. Dong, Y.J. Wang, Fabrication of occulationresistant pH/ionic strength/temperature multiresponsive hollow microspheres
and their controlled release, Mol. Pharmaceutics 9 (2012) 91101.
[30] E. Joussein, S. Petit, J. Churchman, B. Theng, D. Righi, B. Delvaux, Halloysite clay
minerals: a review, Clay Miner. 40 (2005) 383426.
[31] L. Aristilde, C.M. arichal, J. Mih-brend, B. Lanso, L. Charlet, Interactions of
oxytetracycline with a smectite clay: a spectroscopic study with molecular
simulations, Environ. Sci. Technol. 44 (2010) 78397845.
[32] C. Gu, K.G. Karthikeyan, Interaction of tetracycline with aluminum and iron
hydrous oxides, Environ. Sci. Technol. 39 (2005) 26602667.
[33] X.H. Peng, L. Zhang, J.F. Kennedy, Release behavior of microspheres from crosslinked N-methylated chitosan encapsulated ooxacin, Carbohydr. Polym. 65
(2006) 288295.
[34] P.L. Ritger, N.A. Peppas, A simple equation for description of solute release.
I. Fickian and non-Fickian release from non-swellable devices in the form of
slabs, spheres, cylinders or discs, J. Controlled Release 5 (1987) 2336.
[35] J. Siepmanna, N.A. Peppas, Modeling of drug release from delivery systems
based on hydroxypropyl methylcellulose (HPMC), Adv. Drug Delivery Rev. 48
(2001) 139157.